Polydex Pharmaceuticals Limited (OTCMKTS:POLXF – Get Free Report) shares passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.99 and traded as low as $1.99. Polydex Pharmaceuticals shares last traded at $1.99, with a volume of 2,000 shares changing hands.
Polydex Pharmaceuticals Trading Up 0.3 %
The stock has a fifty day simple moving average of $1.99 and a 200-day simple moving average of $1.99. The stock has a market cap of $6.81 million and a price-to-earnings ratio of -8.27.
Polydex Pharmaceuticals Company Profile
Polydex Pharmaceuticals Ltd. is a development stage company, which engages in manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market.
Further Reading
- Five stocks we like better than Polydex Pharmaceuticals
- 3 Warren Buffett Stocks to Buy Now
- High-Yield Texas Instruments Could Hit New Highs Soon
- How to Buy Cheap Stocks Step by Step
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- What Are Dividend Achievers? An Introduction
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.